(MS) Morgan Stanley - NYSE
Sector: Financial Services | Industry: Capital Markets | Exchange: NYSE (USA) | Market Cap: 343.817m USD | Total Return: 72.2% in 12m
Avg Turnover: 1.29B
EPS Trend: 97.3%
Qual. Beats: 3
Rev. Trend: 98.0%
Qual. Beats: 4
Warnings
No concerns identified
Tailwinds
Supp Ema20, Rs Leader, Idiosyncratic Leader, Tailwind, Confidence
Morgan Stanley is a global financial services holding company headquartered in New York. The firm operates through three primary segments: Institutional Securities, Wealth Management, and Investment Management. Its core business includes investment banking, sales and trading, financial advisory, and asset management services for a diverse client base of corporations, governments, and individuals.
The company functions within the Investment Banking & Brokerage sub-industry, where revenue is traditionally driven by advisory fees, underwriting spreads, and net interest income from lending operations. In recent years, the firm has strategically shifted its business model toward Wealth Management to increase its proportion of fee-based, recurring revenue, which typically offers lower volatility than institutional trading and investment banking.
Investors can further evaluate these revenue streams and historical performance trends on ValueRay.
Beyond capital markets, Morgan Stanley provides extensive banking services, including residential real estate loans and commercial lending. Its global footprint allows it to capture deal flow across the Americas, EMEA, and Asia, leveraging its research and prime brokerage divisions to support institutional liquidity and market-making activities.
- Net interest income sensitivity to Federal Reserve monetary policy shifts
- Wealth management asset inflows drive recurring fee-based revenue growth
- Investment banking activity levels dictate advisory and underwriting fee volatility
- Regulatory capital requirements influence share buyback and dividend capacity
- Global equity market performance impacts institutional trading and brokerage commissions
| Net Income: 18.2b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA 2.27 > 1.0 |
| NWC/Revenue: 340.5% < 20% (prev -596.7%; Δ 937.2% < -1%) |
| CFO/TA -0.00 > 3% & CFO -1.01b > Net Income 18.2b |
| Net Debt (-266b) to EBITDA (27.9b): -9.51 < 3 |
| Current Ratio: 1.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.59b) vs 12m ago -0.44% < -2% |
| Gross Margin: 57.99% > 18% (prev 56.30%; Δ 1.69% > 0.5%) |
| Asset Turnover: 8.34% > 50% (prev 8.13%; Δ 0.21% > 0%) |
| Interest Coverage Ratio: 0.47 > 6 (EBIT TTM 23.4b / Interest Expense TTM 50.2b) |
| A: 0.26 (Total Current Assets 1076b - Total Current Liabilities 666b) / Total Assets 1581b |
| B: 0.08 (Retained Earnings 119b / Total Assets 1581b) |
| C: 0.02 (EBIT TTM 23.4b / Avg Total Assets 1441b) |
| D: 0.08 (Book Value of Equity 114b / Total Liabilities 1466b) |
| Altman-Z'' = 2.13 = BBB |
| DSRI: 1.27 (Receivables 133b/92.2b, Revenue 120b/106b) |
| GMI: 0.97 (GM 56.30% / 57.99%) |
| AQI: 0.37 (AQ_t 0.32 / AQ_t-1 0.86) |
| SGI: 1.14 (Revenue 120b / 106b) |
| TATA: 0.01 (NI 18.2b - CFO -1.01b) / TA 1581b) |
| Beneish M = -3.11 (Cap -4..+1) = AA |
As of June 20, 2026, the stock is trading at USD 223.17 with a total of 11,933,200 shares traded.
Over the past week, the price has changed by +4.94%,
over one month by +17.72%,
over three months by +41.51% and
over the past year by +72.22%.
Morgan Stanley has received a consensus analysts rating of 3.68. Therefore, it is recommended to hold MS.
- StrongBuy: 8
- Buy: 2
- Hold: 14
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 203.7 | -8.7% |
P/E Trailing = 19.7446
P/E Forward = 18.2815
P/S = 4.6986
P/B = 3.2295
P/EG = 2.5733
Revenue TTM = 120b USD
EBIT TTM = 23.4b USD
EBITDA TTM = 27.9b USD
Long Term Debt = 371b USD (from longTermDebt, last quarter)
Short Term Debt = 22.7b USD (from shortTermDebt, last quarter)
Debt = 394b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -266b USD (calculated: Debt 394b - CCE 660b)
Enterprise Value = 78.3b USD (344b + Debt 394b - CCE 660b)
Interest Coverage Ratio = 0.47 (Ebit TTM 23.4b / Interest Expense TTM 50.2b)
EV/FCF = -74.44x (Enterprise Value 78.3b / FCF TTM -1.05b)
FCF Yield = -1.34% (FCF TTM -1.05b / Enterprise Value 78.3b)
FCF Margin = -0.88% (FCF TTM -1.05b / Revenue TTM 120b)
Net Margin = 15.13% (Net Income TTM 18.2b / Revenue TTM 120b)
Gross Margin = 57.99% ((Revenue TTM 120b - Cost of Revenue TTM 50.5b) / Revenue TTM)
Gross Margin QoQ = 61.79% (prev 58.02%)
Tobins Q-Ratio = 0.05 (Enterprise Value 78.3b / Total Assets 1581b)
Interest Expense / Debt = 12.73% (Interest Expense 50.2b / Debt 394b)
Taxrate = 21.90% (5.13b / 23.4b)
NOPAT = 18.3b (EBIT 23.4b * (1 - 21.90%))
Current Ratio = 1.61 (Total Current Assets 1076b / Total Current Liabilities 666b)
Debt / Equity = 3.45 (Debt 394b / totalStockholderEquity, last quarter 114b)
Debt / EBITDA = -9.51 (Net Debt -266b / EBITDA 27.9b)
Debt / FCF = 252.4 (negative FCF - burning cash) (Net Debt -266b / FCF TTM -1.05b)
Total Stockholder Equity = 111b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.26% (Net Income 18.2b / Total Assets 1581b)
RoE = 16.38% (Net Income TTM 18.2b / Total Stockholder Equity 111b)
RoCE = 4.86% (EBIT 23.4b / Capital Employed (Equity 111b + L.T.Debt 371b))
RoIC = 1.96% (NOPAT 18.3b / Invested Capital 932b)
WACC = 10.61% (E(344b)/V(738b) * Re(11.37%) + D(394b)/V(738b) * Rd(12.73%) * (1-Tc(0.22)))
Discount Rate = 11.37% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.09 | Cagr: -0.93%
[DCF] Fair Price = unknown (Cash Flow -1.05b)
EPS Correlation: 97.33 | EPS CAGR: 31.56% | SUE: 2.11 | # QB: 3
Revenue Correlation: 98.04 | Revenue CAGR: 15.39% | SUE: 0.91 | # QB: 4
EPS current Quarter (2026-06-30): EPS=2.77 | Chg30d=-0.19% | Revisions=+44% | Analysts=14
EPS next Quarter (2026-09-30): EPS=2.90 | Chg30d=-0.01% | Revisions=+0% | Analysts=14
EPS current Year (2026-12-31): EPS=11.85 | Chg30d=-0.16% | Revisions=+74% | GrowthEPS=+16.1% | GrowthRev=+9.6%
EPS next Year (2027-12-31): EPS=12.70 | Chg30d=-0.35% | Revisions=+74% | GrowthEPS=+7.1% | GrowthRev=+4.8%
[Analyst] Revisions Ratio: +74%